Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 360 participants.
Also called NCT01918722
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 360 participants
- Registry
-
NCT01918722
-
- Other papers using this trial's data
- Safety and efficacy of herbal medicine for acute intracerebral hemorrhage (CRRICH): a multicentre randomised controlled trial
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01918722. Randomized; quadruple masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2016-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy
- Condition
- Intracerebral Hemorrhage
- Intervention (Drug)
- ICH-1(herbal medicine with Hirudo, Tabanus)
- Intervention (Drug)
- placebo
- Intervention (Drug)
- ICH-2(herbal medicine without Hirudo, Tabanus)
- Lead sponsor
- Guangzhou University of Traditional Chinese Medicine
Record details
- Record id
cardio:ct-nct01918722- Content hash
b793a7b7f2557608d2d2772e0ee1151f5edcdbab24156392040f30d47f5a606d